INSIGHTS ON CLINICAL TRIAL PARTNERING

• Considerations For Drug-Device Combination Products In Rare Diseases

  The development process for these products is complex, requiring careful consideration of regulatory requirements, technical feasibility, clinical efficacy, and patient-centered design.

• Central eSource Is The Latest In Sponsor Provided Site Offerings

  For decades, sponsors have provided tools to help clinical sites work more efficiently. Central eSource is the latest evolution in this trend.

• Dispelling Common Clinical Trial Oversight Myths

  Many clinical trial oversight problems can be avoided or mitigated by sponsor understanding root causes and being a proactive collaborator with its partners.

• Why Biotech CRO Partnerships Are Essential For Clinical Trial Success

  For early-stage biotech companies, the road from discovery to market is fraught with challenges, and in this environment, strategic partnerships with CROs have become a cornerstone of clinical success.

• Clinical Trial Payments And Ethics: Your Top Questions Answered

  5/22/2025

  Fair compensation in trials requires distinguishing reimbursement from stipends. Learn the ethical principles that ensure payments uphold participant respect and remove financial barriers.

• Navigating The Complexities Of Clinical Trial Site Payments Forecasting

  7/9/2024

  Advanced technology and best practices have the potential to revolutionize clinical trial site payment forecasting, leading to significant improvements in overall trial efficiency and management.

• Clinical Trials In The Age Of Cost Caps

  4/14/2025

  On February 7, 2025, the NIH introduced a pivotal policy (NOT-OD-25-068), capping indirect cost recovery at 15% for research grants.

• Global Vaccine Trials Case Study

  5/22/2024

  Explore targeted strategies for tackling the complexities of international payments and providing comprehensive participant support in global vaccine trials.

• Participant Payments: Navigating Modern Studies

  12/18/2024

  To address the challenges of disbursing clinical trial participant payments globally, sponsors need region-specific payment solutions that navigate local laws and banking systems.